In addition, about 50% patients have anti-myelin-associated glycoprotein (anti-MAG) IgM antibodies in the serum or biopsies, and may have a different pathogenesis to CIDP (71). This evidence concerns the gene MAG and chronic inflammatory demyelinating polyradiculoneuropathy.